Pages that link to "Q34937231"

The following pages link to Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment (Q34937231):

Displaying 50 items.

• Natural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic Infection (Q26775036) ‎ (← links)
• Interferon-alpha, immune activation and immune dysfunction in treated HIV infection (Q26861003) ‎ (← links)
• A Review of Management of Inflammation in the HIV Population (Q28078962) ‎ (← links)
• Cardiovascular Complications of HIV-Associated Immune Dysfunction (Q28084981) ‎ (← links)
• Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART (Q28476094) ‎ (← links)
• KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy (Q28477797) ‎ (← links)
• Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe (Q28539369) ‎ (← links)
• Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada (Q28610686) ‎ (← links)
• Thoughts on intervention in HIV/AIDS with traditional Chinese medicine (Q30414795) ‎ (← links)
• Effects of laboratory data exchange in the care of patients with HIV. (Q30558425) ‎ (← links)
• High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort (Q30999041) ‎ (← links)
• Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients (Q33432729) ‎ (← links)
• Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa (Q33580153) ‎ (← links)
• Microbial translocation and cardiometabolic risk factors in HIV infection (Q33713895) ‎ (← links)
• Qualitative immune modulation by interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patients (Q33760657) ‎ (← links)
• Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study (Q33781469) ‎ (← links)
• Effect of early versus deferred antiretroviral therapy for HIV on survival (Q33789114) ‎ (← links)
• When to start antiretroviral therapy (Q33799012) ‎ (← links)
• Prevalence, trend and risk factors for antiretroviral therapy discontinuation among HIV-infected adults in Ethiopia in 2003-2015 (Q33807108) ‎ (← links)
• The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment (Q33813372) ‎ (← links)
• Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology (Q33827819) ‎ (← links)
• Trend of CD4+ Cell Counts at Diagnosis and Initiation of Highly Active Antiretroviral Therapy (HAART): Korea HIV/AIDS Cohort Study, 1992-2015 (Q33880384) ‎ (← links)
• Time to immunologic recovery and determinant factors among adults who initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia. (Q33909241) ‎ (← links)
• Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS (Q33916321) ‎ (← links)
• Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database (Q33933071) ‎ (← links)
• Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion (Q33987485) ‎ (← links)
• Residual immune dysregulation syndrome in treated HIV infection (Q34020121) ‎ (← links)
• Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti (Q34031173) ‎ (← links)
• Short-course antiretroviral therapy in primary HIV infection (Q34037516) ‎ (← links)
• Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study (Q34065045) ‎ (← links)
• HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment (Q34140484) ‎ (← links)
• Gender differences in immune reconstitution: a multicentric cohort analysis in sub-Saharan Africa (Q34170487) ‎ (← links)
• Dysregulation of multiple inflammatory molecules in lymph node and ileum of macaques during RT-SHIV infection with or without antiretroviral therapy (Q34250336) ‎ (← links)
• Immune activation and HIV persistence: implications for curative approaches to HIV infection (Q34351320) ‎ (← links)
• Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in Thailand (Q34385049) ‎ (← links)
• Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection (Q34477711) ‎ (← links)
• The economic burden of late entry into medical care for patients with HIV infection (Q34497355) ‎ (← links)
• Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort (Q34569335) ‎ (← links)
• Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells (Q34600441) ‎ (← links)
• HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis (Q34625399) ‎ (← links)
• Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals (Q34666498) ‎ (← links)
• A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response (Q34743336) ‎ (← links)
• Update in HIV medicine for the generalist. (Q34799053) ‎ (← links)
• Incomplete normalization of regulatory t-cell frequency in the gut mucosa of Colombian HIV-infected patients receiving long-term antiretroviral treatment (Q34963393) ‎ (← links)
• Among patients with sustained viral suppression in a resource-limited setting, CD4 gains are continuous although gender-based differences occur (Q34981015) ‎ (← links)
• Higher CD27+CD8+ T cells percentages during suppressive antiretroviral therapy predict greater subsequent CD4+ T cell recovery in treated HIV infection (Q35082803) ‎ (← links)
• Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients (Q35087069) ‎ (← links)
• Delay in cART initiation results in persistent immune dysregulation and poor recovery of T-cell phenotype despite a decade of successful HIV suppression. (Q35141793) ‎ (← links)
• CD4 cell count trends after commencement of antiretroviral therapy among HIV-infected patients in Tigray, Northern Ethiopia: a retrospective cross-sectional study (Q35225198) ‎ (← links)
• Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy (Q35233148) ‎ (← links)